GAM
CERO

Gritstone Asset Management’s CERo Therapeutics CERO Stock Holding History

Gritstone Asset Management’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17
Closed -$363K – 134
2023
Q1 		$363K Hold
17
– – 0.46% 61
2022
Q4 		$349K Buy
+17
New +$347K 0.44% 70

Other funds holding CERO

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gritstone Asset Management's CERO Position: Q2 2023 in Review

Gritstone Asset Management sold out of CERo Therapeutics (CERO) in Q2 2023, closing a stake of 17 shares — an estimated $363K sold.

Gritstone Asset Management first reported a position in CERO in Q4 2022 and held it in 2 quarters. The position peaked at $363K in Q1 2023. 12 funds tracked by Wall St. Rank hold CERO as of Q2 2023.

  • Gritstone Asset Management reported no remaining CERo Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Gritstone Asset Management sold 17 CERo Therapeutics shares in Q2 2023, an estimated $363K.
  • Gritstone Asset Management first reported a position in CERo Therapeutics in Q4 2022 and held it in 2 quarters.
  • Gritstone Asset Management's CERo Therapeutics position peaked at $363K in Q1 2023.
  • 12 funds tracked by Wall St. Rank held CERo Therapeutics as of Q2 2023.

Based on Gritstone Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.